ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)
$7.66 0.45 (6.2413%)
Analysed ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) News Sources
These Are the Only 3 Stocks That Cathie Wood Bought Last Week
23-03-2026
fool.com
Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf
23-03-2026
marketbeat.com
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
25-03-2026
fool.com
Arcturus Therapeutics to Report First Quarter Financial Results and Provide Corporate Update on May 7, 2026
27-04-2026
yahoo.com
Illumina (ILMN) Tops Q1 Earnings and Revenue Estimates
30-04-2026
yahoo.com
Arcturus Therapeutics Announces First Quarter 2026 Financial Results and Pipeline Progress
07-05-2026
yahoo.com
Arcturus Therapeutics Q1 Earnings Call Highlights
07-05-2026
marketbeat.com
Arcturus Therapeutics (ARCT) Reports Q1 Loss, Lags Revenue Estimates
07-05-2026
yahoo.com
Arcturus Therapeutics Holdings Inc. Q1 2026 Earnings Call Summary
08-05-2026
moby.co
Arcturus Therapeutics to Present at 2026 Jefferies Global Healthcare Conference
26-05-2026
yahoo.com
What is the current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The current price of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is $7.66.
ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) absolute price change since previous trading day?
The absolute price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is $0.45.
ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) percentage price change since previous trading day?
The percentage price change of ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) since the previous trading day is 6.2413%.
What is the most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The most recent average sentiment score for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is 73 out of 100.
What is the most recent average sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)?
The most recent sentiment for ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ) is .
SEC-8K** Filing Available For ARCTURUS THERAPEUTICS HOLDIN (ARCT:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.